Skip to content

Clinical trials

Neoplasm Metastasis trials in Georgia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Country / region: Georgia Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20141
20171
20191
20203
20215
20222
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Active, not recruiting3
Recruiting3
Terminated2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
Incyte Corporation2
BeiGene1
Checkpoint Therapeutics, Inc.1
G1 Therapeutics, Inc.1
Genmab1
Immuneering Corporation1
Imugene Limited1
Janssen Research & Development, LLC1
Queen Mary University of London1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis16
Carcinoma, Non-Small-Cell Lung4
Breast Neoplasms3
Endometrial Neoplasms2
Triple Negative Breast Neoplasms2
Adenocarcinoma1
Anemia1
Gastrointestinal Neoplasms1
Lung Neoplasms1
Melanoma1

Trials

Showing 76 to 16 of 16. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.